ClinicalTrials.gg
Not yet recruitingNCT07950813Updated Nov 20, 2026

Comparison of Combined ACB and IPACK Versus ACB Alone for Postoperative Pain Management After ACL Reconstruction

An interventional study of Ultrasound-Guided Adductor Canal Block (ACB) alone and Ultrasound-Guided combined Adductor Canal Block plus IPACK Block in Postoperative Pain Management and ACL Reconstruction, sponsored by Bangladesh Medical University. Not yet recruiting at 1 site in Bangladesh. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Bangladesh Medical University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate whether combining an adductor canal block (ACB) with an infiltration between the popliteal artery and the knee capsule (IPACK) provides better postoperative analgesia than ACB alone in patients undergoing anterior cruciate ligament reconstruction.

A total of 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II will be randomly allocated into two groups. The intervention group will receive ultrasound-guided combined ACB and IPACK blocks, while the comparator group will receive ultrasound-guided ACB alone. Both groups will receive spinal anesthesia and standardized postoperative analgesia.

Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS) at 2, 6, 12, and 24 hours after surgery. Other outcomes will include total opioid consumption during the first 24 hours, postoperative quality of recovery assessed by the QoR-15 questionnaire, time to first rescue analgesic request, maximum walking distance, and block-related complications.

The findings are expected to provide evidence on the effectiveness of adding an IPACK block to ACB to improve postoperative pain management following ACL reconstruction.

Read the detailed description

Anterior cruciate ligament reconstruction (ACLR) is a commonly performed orthopedic procedure for patients with anterior cruciate ligament injuries. Despite its minimally invasive arthroscopic approach, the procedure is frequently associated with significant postoperative pain due to surgical tissue injury, graft harvesting, tourniquet application, and postoperative inflammatory responses. Inadequate pain management may interfere with early mobilization, delay rehabilitation, increase opioid consumption, and negatively affect postoperative recovery.

Effective postoperative analgesia is therefore an important component of perioperative care following anterior cruciate ligament (ACL) reconstruction. Multimodal analgesia, including regional anesthesia techniques, is increasingly used to improve pain control while minimizing opioid-related adverse effects.

The adductor canal block (ACB) is an ultrasound-guided regional anesthesia technique that primarily targets the saphenous nerve and provides analgesia to the anterior and medial aspects of the knee while generally preserving quadriceps muscle strength. However, adductor canal block (ACB) alone may provide inadequate analgesia for pain originating from the posterior aspect of the knee.

The infiltration between the popliteal artery and the knee capsule (IPACK) block is an ultrasound-guided regional anesthesia technique designed to provide analgesia to the posterior knee capsule while minimizing motor blockade. Combining infiltration between the popliteal artery and the knee capsule (IPACK) with adductor canal block (ACB) may provide more comprehensive postoperative analgesia by addressing both anterior-medial and posterior knee pain.

The present randomized controlled trial is designed to evaluate the effectiveness of combined ultrasound-guided adductor canal block (ACB) and infiltration between the popliteal artery and the knee capsule (IPACK) blocks compared with ultrasound-guided adductor canal block (ACB) alone in patients undergoing arthroscopic anterior cruciate ligament reconstruction.

The study will include 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II who are scheduled for anterior cruciate ligament (ACL) reconstruction. Participants will be recruited using consecutive sampling and randomly allocated 1:1 to two study groups using computer-generated block randomization. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. The outcome assessor will remain blinded to the group allocation.

Participants allocated to this group will receive an ultrasound-guided adductor canal block with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided IPACK block with an additional 20 mL of 0.25% bupivacaine.

Participants allocated to this group will receive ultrasound-guided adductor canal block alone using 20 mL of 0.25% bupivacaine.

Both groups will undergo surgery under standard spinal anesthesia. Standardized postoperative analgesia will be provided using intravenous paracetamol (15 mg/kg) every 8 hours. Rescue analgesia with intravenous morphine (3 mg) will be administered when the postoperative Numeric Rating Scale (NRS) pain score exceeds 5, with repeat administration if required.

The study findings will help determine whether adding an IPACK block to an adductor canal block provides improved postoperative analgesia compared with ACB alone following ACL reconstruction.

02

Conditions studied

  • Postoperative Pain Management
  • ACL Reconstruction

Browse trials for

Keywords

  • Anterior Cruciate Ligament (ACL) Reconstruction
  • Adductor Canal Block (ACB)
  • IPACK Block
  • Postoperative Analgesia
03

In context

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,240 are open to participants now.

This study's planned enrollment of 72 is close to the median of 75 across 4,854 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Bangladesh Medical University is the lead sponsor of 46 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient with anterior cruciate ligament injury requiring surgery.
  • Adult patients
  • Patients aged between 18 and 50 years
  • Patients of either sex.
  • (ASA) physical status I-II.

Exclusion criteria

Exclusion Criteria:

  • Known allergy to local anesthetic drugs
  • Coagulopathy or patients receiving anticoagulant therapy
  • Infection at the site of injection
  • Chronic opioid use or opioid dependence
  • Pregnancy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Group IPACK+ACB

    Participants in this group will receive an ultrasound-guided adductor canal block (ACB) with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided infiltration between the popliteal artery and the knee capsule (IPACK) using an additional 20 mL of 0.25% bupivacaine. Both blocks will be administered before surgery. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

    Procedure: Ultrasound-Guided combined Adductor Canal Block plus IPACK Block

  • Active comparator
    Group ACB

    Participants in this group will receive an ultrasound-guided adductor canal block (ACB) alone using 20 mL of 0.25% bupivacaine before surgery. No IPACK block will be administered. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

    Procedure: Ultrasound-Guided Adductor Canal Block (ACB) alone

Interventions

  • ProcedureUltrasound-Guided Adductor Canal Block (ACB) alone

    Ultrasound-guided adductor canal block will be performed with the participant in the supine position. A linear ultrasound transducer will be placed over the mid-thigh to identify the femoral artery and adjacent saphenous nerve beneath the sartorius muscle. After confirming needle placement and careful aspiration, 20 mL of 0.25% bupivacaine will be injected around the saphenous nerve in 5 mL increments.

  • ProcedureUltrasound-Guided combined Adductor Canal Block plus IPACK Block

    Participants will receive an ultrasound-guided combined adductor canal block (ACB) and an infiltration between the popliteal artery and the knee capsule (IPACK) before surgery. The ACB will be performed using 20 mL of 0.25% bupivacaine administered around the saphenous nerve in the adductor canal. The IPACK block will be performed using an additional 20 mL of 0.25% bupivacaine injected into the interspace between the popliteal artery and the posterior capsule of the knee under ultrasound guidance. Both blocks will be administered as a combined regional anesthesia technique for postoperative pain management following anterior cruciate ligament reconstruction.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Intensity Measured by Numeric Rating Scale (NRS)

    Postoperative pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain), both at rest and during movement (knee flexion greater than 45 degrees). Pain scores will be recorded and compared between the two study groups.

    Time frame: 2, 6, 12, and 24 hours after surgery

Secondary outcomes

  1. Time to First Analgesic Request

    The time from the end of surgery to the first request for postoperative rescue analgesia will be recorded in hours and compared between the two study groups.

    Time frame: First 24 hours after surgery

  2. Postoperative Quality of Recovery Measured by QoR-15 Score

    Postoperative quality of recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better recovery quality. Scores will be compared between the two study groups.

    Time frame: 24 hours after surgery

  3. Adverse Effects

    Incidence of Block-Related Adverse Effects

    Time frame: Up to 24 hours following surgery

  4. Total Opioid Consumption During the First 24 Hours After Surgery

    Measure and compare the total opioid consumption between the two study groups during the first 24 hours after surgery. Opioid consumption will be recorded and expressed in morphine-equivalent doses (mg).

    Time frame: First 24 hours after surgery

07

Study locations

1 site
08

References and documents

Publications

  • Kampitak W, Tanavalee A, Tansatit T, Ngarmukos S, Songborassamee N, Vichainarong C. The analgesic efficacy of anterior femoral cutaneous nerve block in combination with femoral triangle block in total knee arthroplasty: a randomized controlled trial. Korean J Anesthesiol. 2021 Dec;74(6):496-505. doi: 10.4097/kja.21120. Epub 2021 Jun 29. PubMed 34182749 ↗
  • Rao N, Triana J, Avila A, Campbell KA, Alaia MJ, Jazrawi LM, Furiguele D, Popovic J, Strauss EJ. Postoperative Pain and Opioid Usage With Combined Adductor Canal and IPACK Block Versus Isolated Adductor Canal Block After Anterior Cruciate Ligament Reconstruction With a Bone-Patellar Tendon-Bone Autograft: A Single-Center Randomized Controlled Trial. Am J Sports Med. 2025 May;53(6):1359-1367. doi: 10.1177/03635465251328609. Epub 2025 May 1. PubMed 40308075 ↗
  • Guo J, Hou M, Shi G, Bai N, Huo M. iPACK block (local anesthetic infiltration of the interspace between the popliteal artery and the posterior knee capsule) added to the adductor canal blocks versus the adductor canal blocks in the pain management after total knee arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res. 2022 Aug 12;17(1):387. doi: 10.1186/s13018-022-03272-5. PubMed 35962410 ↗
  • Zeng J, Yang X, Lei H, Zhong X, Lu X, Liu X, Peng X. Enhanced Postoperative Pain Management and Mobility Following Arthroscopic Knee Surgery: A Comparative Study of Adductor Canal Block with and without IPACK Block. Med Sci Monit. 2024 Jul 28;30:e943735. doi: 10.12659/MSM.943735. PubMed 39068511 ↗
  • Sweeney CM, Bomar JD, Edmonds EW. Effect of IPACK-Adductor Canal Block Combination on Adolescent Pain Management After Hamstring Autograft Anterior Cruciate Ligament Reconstruction. Orthop J Sports Med. 2025 May 23;13(5):23259671251331145. doi: 10.1177/23259671251331145. eCollection 2025 May. PubMed 40416995 ↗
  • Al-Hadithy N, Dodds AL, Akhtar KS, Gupte CM. Current concepts of the management of anterior cruciate ligament injuries in children. Bone Joint J. 2013 Nov;95-B(11):1562-9. doi: 10.1302/0301-620X.95B11.31778. PubMed 24151280 ↗
  • Sinha C, Singh AK, Kumar A, Kumar A, Kumar S, Kumari P. Analgesic effect of continuous adductor canal block versus continuous femoral nerve block for knee arthroscopic surgery: a randomized trial. Braz J Anesthesiol. 2022 Sep-Oct;72(5):553-559. doi: 10.1016/j.bjane.2021.03.017. Epub 2021 Apr 24. PubMed 33901552 ↗
  • Bailey L, Griffin J, Elliott M, Wu J, Papavasiliou T, Harner C, Lowe W. Adductor Canal Nerve Versus Femoral Nerve Blockade for Pain Control and Quadriceps Function Following Anterior Cruciate Ligament Reconstruction With Patellar Tendon Autograft: A Prospective Randomized Trial. Arthroscopy. 2019 Mar;35(3):921-929. doi: 10.1016/j.arthro.2018.10.149. Epub 2019 Feb 4. PubMed 30733025 ↗
  • Stebler K, Martin R, Kirkham KR, Lambert J, De Sede A, Albrecht E. Adductor canal block versus local infiltration analgesia for postoperative pain after anterior cruciate ligament reconstruction: a single centre randomised controlled triple-blinded trial. Br J Anaesth. 2019 Aug;123(2):e343-e349. doi: 10.1016/j.bja.2019.04.053. Epub 2019 May 24. PubMed 31130273 ↗
  • Kertkiatkachorn W, Kampitak W, Tanavalee A, Ngarmukos S. Adductor Canal Block Combined With iPACK (Interspace Between the Popliteal Artery and the Capsule of the Posterior Knee) Block vs Periarticular Injection for Analgesia After Total Knee Arthroplasty: A Randomized Noninferiority Trial. J Arthroplasty. 2021 Jan;36(1):122-129.e1. doi: 10.1016/j.arth.2020.06.086. Epub 2020 Jul 2. PubMed 32694032 ↗
  • Laoruengthana A, Rattanaprichavej P, Kositanurit I, Saenghirunvattana C, Samapath P, Pongpirul K. Adductor Canal Block Combined with Interspace between the Popliteal Artery and Capsule of the Knee (iPACK) versus Periarticular Injection for Total Knee Arthroplasty. Clin Orthop Surg. 2022 Dec;14(4):514-521. doi: 10.4055/cios21108. Epub 2022 Jun 30. PubMed 36518937 ↗
  • Roy R, Agarwal G, Ahuja P, Mohta A. Response to comments on article: Adductor canal block (ACB) plus infiltration of the posterior capsule of the knee (iPACK) block versus 4-in-1 block in an arthroscopic anterior cruciate ligament (ACL) repair: A randomised study. Indian J Anaesth. 2025 Feb;69(2):252-253. doi: 10.4103/ija.ija_1173_24. Epub 2025 Jan 29. No abstract available. PubMed 40160920 ↗
  • Roy R, Agarwal G, Ahuja P, Mohta A. Adductor canal block (ACB) plus infiltration of the posterior capsule of the knee (iPACK) block versus 4-in-1 block in an arthroscopic anterior cruciate ligament (ACL) repair: A randomised study. Indian J Anaesth. 2024 Nov;68(11):959-964. doi: 10.4103/ija.ija_671_24. Epub 2024 Oct 26. PubMed 39659538 ↗
  • Roy R, Agarwal G, Latwal BS, Patel A, Mohta A. A comparative randomized controlled study of modified 4 in 1 block versus IPACK plus adductor canal block for post-operative analgesia in total knee arthroplasty. Indian J Anaesth. 2023 Mar;67(3):296-301. doi: 10.4103/ija.ija_530_22. Epub 2023 Mar 16. PubMed 37250512 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for May 2027, 5 months later.

Of 2,107 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 5 months is below that.

Counting every sponsor, half of 2,120 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 20, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
May 31, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07950813
Lead sponsor
Bangladesh Medical University
Responsible party
Kazi Mahzabin Arin (Assistant Professor, Bangladesh Medical University) — Principal investigator
First posted
Nov 20, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Kazi Mahzabin Arin, MD
Contact
kazimahzabinarin@bmu.ac.bd
+8801754057689
AKM Akhtaruzzaman, MD
Contact
akm.akhtaruzzaman@bmu.ac.bd
+8801819220195

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion